Medicine & Life Sciences

1. Pediatrics 100%
2. Kidney 94%
3. Transplant Recipients 71%
4. fibroblast growth factor 23 69%
5. burosumab 58%
6. Immunosuppression 56%
7. Transplants 53%
8. Maintenance 41%
9. Kidney Transplantation 38%
10. Phosphates 34%
11. Continuous Renal Replacement Therapy 33%
12. Steroids 29%
13. Cytomegalovirus Infections 27%
14. Kidney Diseases 26%
15. Chronic Renal Insufficiency 25%
16. Vasculitis 25%
17. Cytomegalovirus 25%
18. Antibodies 23%
19. Chronic Kidney Failure 22%
20. Anemia 21%
21. Homeostasis 21%
22. Graft Survival 19%
23. Transplantation 19%
24. Therapeutics 17%
25. Child 17%
26. Plasma Exchange 15%
27. Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 15%
28. xenotropic and polytropic retrovirus receptor 14%
29. Allografts 10%
30. Immunosuppressive Agents 10%
31. Vitamin D 10%
32. Chronic Kidney Disease-Mineral and Bone Disorder 9%
33. Mortality 9%
34. Basiliximab 9%
35. Survival 9%
36. Fibroblast Growth Factor Receptors 9%
37. Rituximab 9%
38. Abatacept 8%
39. Pharmacology 8%
40. Focal Segmental Glomerulosclerosis 8%
41. Body Remains 7%
42. Opportunistic Infections 6%
43. Graft Rejection 6%
44. Organ Transplantation 6%
45. Epidemiology 6%
46. Glomerulonephritis 6%
47. Acute Kidney Injury 6%
48. Safety 6%
49. Complement Inactivating Agents 6%